Unknown

Dataset Information

0

Clinical significance of soluble programmed cell death-1 and soluble programmed cell death-ligand 1 in patients with locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy.


ABSTRACT: BACKGROUND:Inhibition of the programmed cell death-1/programmed cell death-ligand 1 (PD-1/PD-L1) axis in combination with radiotherapy may be a promising approach to treat cancer. In the present study, we aimed to evaluate serum soluble PD-1/PD-L1 levels in patients with advanced rectal cancer treated with neoadjuvant chemoradiotherapy (CRT). METHODS:Serum soluble PD-L1 and PD-1 levels were measured using an enzyme-linked immunosorbent assay before and after CRT in 117 patients with low rectal cancer. Changes in the levels of sPD-L1/PD-1 after CRT, and the correlation between sPD-L1/PD-1 level and clinicopathological characteristics or disease-free survival (DFS) were evaluated. RESULTS:sPD-L1 levels significantly increased after CRT (p < 0.0001), whereas sPD-1 levels did not change significantly (p = 0.1050). High sPD-L1 before CRT was significantly associated with younger age (p = 0.044), and after CRT, with lymphovascular invasion (p = 0.021). High sPD-1 before and after CRT was significantly associated with a longer distance of the tumor from the anal verge (both p < 0.001). There was no correlation between sPD-L1 level and local PD-L1 expression on stromal immune cells. High sPD-L1 level after CRT tended to be associated with worse DFS (p = 0.0752). The multivariate analysis could not demonstrate an independent association for sPD-L1 levels after CRT with DFS. CONCLUSIONS:Significant increase of sPD-L1 levels after CRT suggests that anti-PD-L1 therapy might be a potential treatment strategy in combination with CRT in advanced rectal cancer.

SUBMITTER: Tominaga T 

PROVIDER: S-EPMC6390997 | biostudies-literature | 2019

REPOSITORIES: biostudies-literature

altmetric image

Publications

Clinical significance of soluble programmed cell death-1 and soluble programmed cell death-ligand 1 in patients with locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy.

Tominaga Tetsuro T   Akiyoshi Takashi T   Yamamoto Noriko N   Taguchi Senzo S   Mori Seiichi S   Nagasaki Toshiya T   Fukunaga Yosuke Y   Ueno Masashi M  

PloS one 20190226 2


<h4>Background</h4>Inhibition of the programmed cell death-1/programmed cell death-ligand 1 (PD-1/PD-L1) axis in combination with radiotherapy may be a promising approach to treat cancer. In the present study, we aimed to evaluate serum soluble PD-1/PD-L1 levels in patients with advanced rectal cancer treated with neoadjuvant chemoradiotherapy (CRT).<h4>Methods</h4>Serum soluble PD-L1 and PD-1 levels were measured using an enzyme-linked immunosorbent assay before and after CRT in 117 patients wi  ...[more]

Similar Datasets

| S-EPMC9070897 | biostudies-literature
| S-EPMC6989542 | biostudies-literature
| S-EPMC8101236 | biostudies-literature
| S-EPMC4851776 | biostudies-other
| S-EPMC6529751 | biostudies-literature
2019-07-01 | GSE123390 | GEO
| 2638777 | ecrin-mdr-crc
| S-EPMC8421958 | biostudies-literature
| S-EPMC6224241 | biostudies-other